(Bloomberg) — The Covid-19 vaccine being developed by Pfizer and BioNTech prevented more than 90% of infections in a study, the most encouraging scientific advance so far in the battle against the coronavirus. Novavax’s experimental vaccine received a fast-track designation from U.S. regulators.Meanwhile, the pandemic shows no signs of slowing, with worldwide infections surpassing 50 million. Cases in the U.S. topped 100,000 for a fourth day, bringing the nation’s total close to the 10 million mark. U.S. President-elect Joe Biden announced a new 13-member coronavirus task force, and New Jersey is preparing more restrictions.Germany has more severe Covid patients than …read more
Source:: Yahoo Finance
